SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:lnu-66905"
 

Sökning: onr:"swepub:oai:DiVA.org:lnu-66905" > Prevalence and trea...

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe : EURIKA, a cross-sectional observational study

Halcox, Julian P. (författare)
Swansea Univ, UK,Swansea Univ, Inst Life Sci 2, Coll Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
Banegas, Jose R. (författare)
Univ Autonoma Madrid, Spain ; CIBER Epidemiol & Publ Hlth CIBERESP, Spain,Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, IdiPaz, Madrid, Spain.;CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
Roy, Carine (författare)
Hop Bichat Claude Bernard, France,Hop Bichat Claude Bernard, AP HP, INSERM CIC EC 1425, Paris, France.;Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, Paris, France.
visa fler...
Dallongeville, Jean (författare)
Univ Lille Nord France, France,Univ Lille Nord France, Inst Pasteur Lille, INSERM, U744, Lille, France.
De Backer, Guy (författare)
Univ Ghent, Belgium,Univ Ghent, Dept Publ Hlth, Ghent, Belgium.
Guallar, Eliseo (författare)
Johns Hopkins Bloomberg Sch Publ Hlth, USA,Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.;Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA.;Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA.
Perk, Joep, 1945- (författare)
Linnéuniversitetet,Institutionen för hälso- och vårdvetenskap (HV),Linnaeus Univ, Sch Hlth & Caring Sci, Kalmar, Sweden.
Hajage, David (författare)
Hop Bichat Claude Bernard, France,Hop Bichat Claude Bernard, AP HP, INSERM CIC EC 1425, Paris, France.;Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, Paris, France.
Henriksson, Karin M. (författare)
Uppsala universitet,Kardiovaskulär epidemiologi
Borghi, Claudio (författare)
Univ Bologna, Italy,Univ Bologna, Dept Internal Med Ageing & Clin Nephrol, Bologna, Italy.
visa färre...
Swansea Univ, UK Swansea Univ, Inst Life Sci 2, Coll Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales (creator_code:org_t)
BioMed Central, 2017
2017
Engelska.
Ingår i: BMC Cardiovascular Disorders. - : BioMed Central. - 1471-2261 .- 1471-2261. ; 17
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet markers of this condition are often ignored in clinical practice. Here, we address a clear evidence gap by assessing the prevalence and treatment of two markers of atherogenic dyslipidemia: elevated triglyceride levels and low levels of high-density lipoprotein cholesterol. Methods: This cross-sectional observational study assessed the prevalence of two atherogenic dyslipidemia markers, high triglyceride levels and low high-density lipoprotein cholesterol levels, in the study population from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; N = 7641; of whom 51.6% were female and 95.6% were White/Caucasian). The EURIKA population included European patients, aged at least 50 years with at least one cardiovascular risk factor but no history of cardiovascular disease. Results: Over 20% of patients from the EURIKA population have either triglyceride or high-density lipoprotein cholesterol levels characteristic of atherogenic dyslipidemia. Furthermore, the proportions of patients with one of these markers were higher in subpopulations with type 2 diabetes mellitus or those already calculated to be at high risk of cardiovascular disease. Approximately 55% of the EURIKA population who have markers of atherogenic dyslipidemia are not receiving lipid-lowering therapy. Conclusions: A considerable proportion of patients with at least one major cardiovascular risk factor in the primary cardiovascular disease prevention setting have markers of atherogenic dyslipidemia. The majority of these patients are not receiving optimal treatment, as specified in international guidelines, and thus their risk of developing cardiovascular disease is possibly underestimated.

Ämnesord

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Atherogenic dyslipidemia
Cardiovascular disease
Epidemiology
Risk factors/global assessment
Health and Caring Sciences
Hälsovetenskap

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy